Effect [qlco]    
drug use [ftcn]    
antidiabetic [phsu]    
Antioxidant [phsu]    
Liver function test [lbpr]    
Marker [clna]    
Diabetes Mellitus, Type 2 [dsyn]    
Subject [grup]    
Pilot [prog]    
Study Objective [idcn]    
Present [qnco]    
studies [mnob]    
Analyzed [resa]    
Effect [qlco]    
antidiabetic drug [phsu]    
Antioxidant [phsu]    
Liver function test [lbpr]    
Marker [clna]    
Associate [menp]    
With [qlco]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Type 2 [clas]    
Diabetes [fndg]    
Subject [grup]    
Method [inpr]    
Assess [acty]    
Health [idcn]    
Diabetes [fndg]    
Subject [grup]    
Diabetes [fndg]    
Subject [grup]    
Divide [ftcn]    
base [ftcn]    
treatment [ftcn]    
Only [qnco]    
Combination [qlco]    
antidiabetic drug [phsu]    
Combination [qlco]    
antidiabetic drug [phsu]    
Liver function test [lbpr]    
Marker [clna]    
Antioxidant [phsu]    
Status [qlco]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Assess [acty]    
Subject [grup]    
Result [ftcn]    
superoxide dismutase activity [moft]    
High [qlco]    
catalase activity [moft]    
Lower [spco]    
Diabetes [fndg]    
Subject [grup]    
Compare [acty]    
Control [grup]    
Level [qlco]    
High [qlco]    
Diabetes [fndg]    
Male [fndg]    
Subject [grup]    
Level [qlco]    
Lower [spco]    
Level [qlco]    
High [qlco]    
Diabetes [fndg]    
Female [fndg]    
Subject [grup]    
Male [fndg]    
Subject [grup]    
Only [qnco]    
Positive [qnco]    
Associate [menp]    
Between [spco]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Seen [qlco]    
Positive [qnco]    
Associate [menp]    
Between [spco]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Seen [qlco]    
Male [fndg]    
Receive [qlco]    
Drug [phsu]    
Female [fndg]    
Subject [grup]    
Display [ftcn]    
Positive [qnco]    
Associate [menp]    
Between [spco]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Only [qnco]    
Positive [qnco]    
Associate [menp]    
Of [spco]    
Homeostasis model assessment [lbpr]    
Insulin Resistance [patf]    
Seen [qlco]    
Female [fndg]    
Combination [qlco]    
Diabetes [fndg]    
Drug [phsu]    
Conclusion [idcn]    
Alteration [idcn]    
antioxidant activity [moft]    
Liver function test [lbpr]    
depend [qlco]    
Gender [orga]    
glycemia [carb]    
Status [qlco]    
Subject [grup]    
Variation [qlco]    
Correlated [qlco]    
Of [spco]    
Homeostasis model assessment [lbpr]    
Insulin Resistance [patf]    
Antioxidant [phsu]    
Liver function test [lbpr]    
Inflammatory [ftcn]    
Marker [clna]    
depend [qlco]    
Type [qlco]    
treatment [topp]    
